Literature DB >> 19533257

De novo synthesis of human dermis in vitro in the absence of a three-dimensional scaffold.

Tara Pouyani1, Vincent Ronfard, Paul G Scott, Carole M Dodd, Aftab Ahmed, Richard L Gallo, Nancy L Parenteau.   

Abstract

Neonatal human dermal fibroblasts cultured in vitro synthesize an organized and physically substantial three-dimensional extracellular matrix, without the addition of exogenous matrix components or synthetic scaffolds. De novo matrix synthesis proceeds in an orderly manner over a 21-d culture period and beyond. Analysis of the fibroblast phenotype, i.e., matrix synthesis by the fibroblasts, suggests that both serum and serum-free conditions are conducive to the production of a human tissue-engineered "dermal equivalent". We report that given the appropriate permissive environment, the fibroblasts establish and grow a tissue in vitro, which bears striking biochemical and physical resemblance to normal human dermis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533257     DOI: 10.1007/s11626-009-9213-6

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  43 in total

1.  Skin: the first tissue-engineered products.

Authors:  N Parenteau
Journal:  Sci Am       Date:  1999-04       Impact factor: 2.142

Review 2.  Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation.

Authors:  Kristen R Taylor; Richard L Gallo
Journal:  FASEB J       Date:  2006-01       Impact factor: 5.191

Review 3.  Mammalian fetal organ regeneration.

Authors:  Amy S Colwell; Michael T Longaker; H Peter Lorenz
Journal:  Adv Biochem Eng Biotechnol       Date:  2005       Impact factor: 2.635

4.  Optimization and characterization of an engineered human skin equivalent.

Authors:  Annie F Black; Charbel Bouez; Eric Perrier; Kordula Schlotmann; François Chapuis; Odile Damour
Journal:  Tissue Eng       Date:  2005 May-Jun

5.  Development of a bilayered living skin construct for clinical applications.

Authors:  L M Wilkins; S R Watson; S J Prosky; S F Meunier; N L Parenteau
Journal:  Biotechnol Bioeng       Date:  1994-04-05       Impact factor: 4.530

6.  L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissuelike substance by skin fibroblasts.

Authors:  R Hata; H Senoo
Journal:  J Cell Physiol       Date:  1989-01       Impact factor: 6.384

7.  Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes.

Authors:  S T Boyce; D J Christianson; J F Hansbrough
Journal:  J Biomed Mater Res       Date:  1988-10

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness.

Authors:  E Bell; H P Ehrlich; D J Buttle; T Nakatsuji
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

10.  Wound tissue can utilize a polymeric template to synthesize a functional extension of skin.

Authors:  I V Yannas; J F Burke; D P Orgill; E M Skrabut
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

View more
  9 in total

1.  Tissue-engineered fetal dermal matrices.

Authors:  Tara Pouyani; Suzanne Papp; Lana Schaffer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-09-06       Impact factor: 2.416

2.  Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds.

Authors:  Anna G Maione; Yevgeny Brudno; Olivera Stojadinovic; Lara K Park; Avi Smith; Ana Tellechea; Ermelindo C Leal; Cathal J Kearney; Aristidis Veves; Marjana Tomic-Canic; David J Mooney; Jonathan A Garlick
Journal:  Tissue Eng Part C Methods       Date:  2015-03-31       Impact factor: 3.056

3.  Survival of Allogeneic Self-Assembled Cultured Skin.

Authors:  Mihail Climov; Abraham J Matar; Evan A Farkash; Erika Medeiros; Jizeng Qiao; Edward Harrington; Ashley Gusha; Ahmad Al-Musa; David H Sachs; Mark Randolph; Thomas J Bollenbach; Christene A Huang
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

4.  PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation.

Authors:  Kyle J Hewitt; Yulia Shamis; Elana Knight; Avi Smith; Anna Maione; Addy Alt-Holland; Steven D Sheridan; Stephen J Haggarty; Jonathan A Garlick
Journal:  J Cell Sci       Date:  2012-02-17       Impact factor: 5.285

5.  iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins.

Authors:  Yulia Shamis; Kyle J Hewitt; Susan E Bear; Addy Alt-Holland; Hiba Qari; Mariam Margvelashvilli; Elana B Knight; Avi Smith; Jonathan A Garlick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-19       Impact factor: 2.416

6.  Triiodothyronine (T3) inhibits hyaluronate synthesis in a human dermal equivalent by downregulation of HAS2.

Authors:  Tara Pouyani; Basma H Sadaka; Suzanne Papp; Lana Schaffer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-09       Impact factor: 2.416

7.  Bioengineered Self-assembled Skin as an Alternative to Skin Grafts.

Authors:  Mihail Climov; Erika Medeiros; Evan A Farkash; Jizeng Qiao; Cecile F Rousseau; Shumin Dong; Agatha Zawadzka; Waldemar J Racki; Ahmad Al-Musa; David H Sachs; Mark A Randolph; Christene A Huang; Thomas J Bollenbach
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-06-10

Review 8.  Engineering Tissues without the Use of a Synthetic Scaffold: A Twenty-Year History of the Self-Assembly Method.

Authors:  Ingrid Saba; Weronika Jakubowska; Stéphane Bolduc; Stéphane Chabaud
Journal:  Biomed Res Int       Date:  2018-03-08       Impact factor: 3.411

9.  Evaluation of a Serum-Free Medium for Human Epithelial and Stromal Cell Culture.

Authors:  Christophe Caneparo; Stéphane Chabaud; Julie Fradette; Stéphane Bolduc
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.